Inogen (INGN) Cash & Equivalents Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -36.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.99% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.52% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.25% |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 57.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.43% |
| Dec 31, 2025 | -17.84% |
| Sep 30, 2025 | -20.21% |
| Jun 30, 2025 | -22.60% |
| Mar 31, 2025 | -17.71% |
| Dec 31, 2024 | -20.71% |
| Sep 30, 2024 | -24.09% |
| Jun 30, 2024 | -25.71% |
| Mar 31, 2024 | -21.25% |
| Dec 31, 2023 | -16.03% |
| Sep 30, 2023 | -51.95% |
| Jun 30, 2023 | -7.82% |
| Mar 31, 2023 | -51.44% |
| Dec 31, 2022 | -1.89% |
| Sep 30, 2022 | 10.32% |
| Jun 30, 2022 | 85.85% |
| Mar 31, 2022 | 122.78% |
| Dec 31, 2021 | 6.20% |
| Sep 30, 2021 | 11.07% |
| Jun 30, 2021 | 12.82% |
| Mar 31, 2021 | 72.07% |
| Dec 31, 2020 | 66.12% |
| Sep 30, 2020 | 61.64% |
| Jun 30, 2020 | 54.52% |
| Mar 31, 2020 | 25.62% |
| Dec 31, 2019 | 28.72% |
| Sep 30, 2019 | 21.99% |
| Jun 30, 2019 | -25.58% |
| Mar 31, 2019 | -35.64% |
| Dec 31, 2018 | 43.82% |
| Sep 30, 2018 | 47.36% |
| Jun 30, 2018 | 47.51% |
| Mar 31, 2018 | -10.92% |
| Dec 31, 2017 | -6.65% |
| Sep 30, 2017 | -3.37% |
| Jun 30, 2017 | -5.63% |
| Mar 31, 2017 | 20.85% |
| Dec 31, 2016 | 90.08% |
| Sep 30, 2016 | 85.29% |
| Jun 30, 2016 | 70.46% |
| Mar 31, 2016 | 72.39% |
| Dec 31, 2015 | 63.55% |